{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:29:28Z","timestamp":1792657768938,"version":"4.5.0"},"reference-count":18,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T00:00:00Z","timestamp":1205712000000},"content-version":"vor","delay-in-days":4977,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1994,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>OBJECTIVE <\/jats:bold> Thyrotoxic periodic paralysis (TPP) usually follows a heavy carbohydrate meal and this may be explained by hyperinsulinaemia stimulating Na<jats:sup>+<\/jats:sup>, K<jats:sup>+<\/jats:sup> \u2010ATPase activity. To clarify this the effect of glucose load on serum insulin concentration and platelet Na<jats:sup>+<\/jats:sup>, K<jats:sup>+<\/jats:sup> \u2010ATPase activity In thyrotoxic periodic paralysis (TPP) was examined.<\/jats:p><jats:p><jats:bold>DESIGN <\/jats:bold> In all subjects a standard 75\u2010g glucose tolerance test was done and blood samples were taken at 0, 1 and 2 hours.<\/jats:p><jats:p><jats:bold>SUBJECTS <\/jats:bold> Twenty\u2010five healthy controls (8 M and 17 F), 17 uncomplicated thyrotoxic patients (7M and 10 F), 15 TPP patients who presented with paralysis and 4 TPP patients after treatment with antithyrold drugs.<\/jats:p><jats:p><jats:bold>MEASUREMENTS <\/jats:bold> Plasma glucose was measured by the glucose oxidase method, serum insulin by radioimmunoassay and platelet Na<jats:sup>+<\/jats:sup>, K<jats:sup>+<\/jats:sup> \u2010ATPase by the release of phosphate from ATP.<\/jats:p><jats:p><jats:bold>RESULTS <\/jats:bold> TPP patients showed glucose intolerance (area under the curve (AUC) 16\u00b75 \u00b1 4\u00b74 (mean \u00b1 SD) In TPP compared to 12\u00b79 \u00b1 4\u00b75 In controls (<jats:italic>P<\/jats:italic> &lt; 0\u00b701) and hyperinsulinaemia (AUC 189\u00b76 \u00b1100\u00b76 <jats:italic>vs<\/jats:italic> 98\u00b75 \u00b153\u00b74, <jats:italic>P<\/jats:italic> &lt; 0\u00b7001). In uncomplicated thyrotoxicosis the results were similar to that in healthy controls. Platelet Na<jats:sup>+<\/jats:sup>, K<jats:sup>+<\/jats:sup> \u2010ATPase were significantly higher in thyrotoxic patients compared to controls and In TPP patients were even higher. Ingestion of glucose increased platelet Na<jats:sup>+<\/jats:sup>, K<jats:sup>+<\/jats:sup> \u2010ATPase in all groups. AUC for platelet Na<jats:sup>+<\/jats:sup>, K<jats:sup>+<\/jats:sup> \u2010ATPase in TPP patients were significantly higher than in uncomplicated thyrotoxicosis (601 \u00b199\u00b73 <jats:italic>vs<\/jats:italic> 482 \u00b1 109\u00b74, <jats:italic>P<\/jats:italic> &lt; 0\u00b701) or healthy controls (320 \u00b1 107\u00b73). In the 4 TPP patients studied after antithyroid treatment the results were similar to healthy controls.<\/jats:p><jats:p><jats:bold>CONCLUSION <\/jats:bold> Patients with thyrotoxic periodic paralysis have hyperinsulinaemia and this is accompanied by higher Na<jats:sup>+<\/jats:sup>, K<jats:sup>+<\/jats:sup>\u2010ATPase activity.<\/jats:p>","DOI":"10.1111\/j.1365-2265.1994.tb02532.x","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T10:41:48Z","timestamp":1205750508000},"page":"213-216","source":"Crossref","is-referenced-by-count":62,"title":["Hyperinsulinaemia and Na<sup>+<\/sup>, K<sup>+<\/sup> \u2010ATPase activity in thyrotoxic periodic paralysis"],"prefix":"10.1111","volume":"41","author":[{"given":"A.","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Shinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. C.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. S.","family":"Cockram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,3,17]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(92)90107-Z"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.303.6810.1096"},{"key":"e_1_2_1_4_1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/clinchem\/35.2.315","article-title":"Effectiveness of sodium fluoride on a preservative of glucose in blood","volume":"35","author":"Chan A.Y.W.","year":"1989","journal-title":"Clinical Chemistry"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1986.66.3.542"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1989.1"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.4.5999.761"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/icb\/28.2.363"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)91710-C"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)52451-6"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5538.451"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1042\/cs0780199"},{"key":"e_1_2_1_13_1","first-page":"219","volume-title":"Progress in Thyroid Research","author":"Shinde R.","year":"1991"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(72)90071-6"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(98)90013-0"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(89)90065-6"},{"key":"e_1_2_1_17_1","first-page":"1341","volume-title":"Progress in Endocrinology","author":"Yeo P.P.B.","year":"1988"},{"key":"e_1_2_1_18_1","first-page":"10","volume-title":"Oxford Textbook of Medicine","author":"Yeung R.T.T.","year":"1987"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(74)90010-2"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.1994.tb02532.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.1994.tb02532.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T02:44:02Z","timestamp":1698115442000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.1994.tb02532.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,8]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1994,8]]}},"alternative-id":["10.1111\/j.1365-2265.1994.tb02532.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.1994.tb02532.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,8]]}}}